BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7721029)

  • 1. Cephalexin concentrations in radicular granuloma following a single oral administration of 250- or 500-mg cephalexin.
    Akimoto Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kawana T; Kaneko K; Fujii A; Kaneda T
    Gen Pharmacol; 1994 Dec; 25(8):1563-6. PubMed ID: 7721029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampicillin concentrations in human radicular granuloma following a single oral dose of bacampicillin.
    Akimoto Y; Kaneko K; Fujii A; Yamamoto H
    J Oral Maxillofac Surg; 1992 Jan; 50(1):11-3. PubMed ID: 1727454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cephalexin concentrations in human serum, gingiva, and mandibular bone following a single oral administration.
    Akimoto Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Fujii A
    Gen Pharmacol; 1990; 21(5):621-3. PubMed ID: 2276582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Josamycin concentrations in human dental granuloma after a single oral administration of josamycin.
    Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Akimoto Y; Kaneko K; Fujii A
    Gen Pharmacol; 1989; 20(6):823-5. PubMed ID: 2591712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefaclor concentration in radicular granuloma after a single oral administration.
    Akimoto Y; Ikeda M; Omata H; Shibutani J; Fujii A; Kaneda T; Yamamoto H; Takato T
    Gen Pharmacol; 1998 Aug; 31(2):283-5. PubMed ID: 9688473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ampicillin concentrations in radicular cysts following a single oral administration of bacampicillin.
    Akimoto Y; Mochizuki Y; Uda A; Shibutani J; Nishimura H; Komiya M; Kaneko K; Fujii A; Yamamoto H
    Gen Pharmacol; 1993 Jul; 24(4):895-8. PubMed ID: 8224746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefaclor concentrations in human serum, gingiva, mandibular bone, and dental follicle following a single oral administration.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Fujii A
    Gen Pharmacol; 1992 Jul; 23(4):639-42. PubMed ID: 1397970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Josamycin concentrations in radicular cysts following a single oral administration.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Saito S; Kaneko K; Fujii A; Yamamoto H
    Gen Pharmacol; 1993 Jan; 24(1):143-5. PubMed ID: 8482488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of lomefloxacin in radicular cyst and oral tissues following single or multiple oral administration.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Kawana T; Fujii A
    J Nihon Univ Sch Dent; 1993 Dec; 35(4):267-75. PubMed ID: 8158288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefadroxil concentrations in human serum, gingiva, and mandibular bone following a single oral administration.
    Akimoto Y; Komiya M; Kaneko K; Fujii A
    J Oral Maxillofac Surg; 1994 Apr; 52(4):397-400; discussion 400-1. PubMed ID: 8133373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampicillin concentrations in human dental granuloma after a single oral administration of talampicillin.
    Akimoto Y; Nishimura H; Komiya M; Kaneko K; Fujii A; Tamura T
    Antimicrob Agents Chemother; 1988 Apr; 32(4):566-7. PubMed ID: 3377465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ampicillin concentrations in human oral tissues following a single oral administration of lenampicillin.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Kaneko K; Yamane J; Fujii A; Yamamoto H
    Gen Pharmacol; 1991; 22(5):797-800. PubMed ID: 1761182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of cephalexin from two oral formulations in dogs].
    Ehinger AM; Kietzmann M
    Berl Munch Tierarztl Wochenschr; 2002; 115(1-2):57-61. PubMed ID: 11852685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cephalexin in dogs and cats after oral, subcutaneous and intramuscular administration.
    Silley P; Rudd AP; Symington WM; Tait AJ
    Vet Rec; 1988 Jan; 122(1):15-7. PubMed ID: 3363802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapeutic effectiveness of cephalexin in dental diseases].
    Balercia A; De Biasi V
    Minerva Stomatol; 1974; 23(1):38-40. PubMed ID: 4528337
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
    Davis JL; Salmon JH; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalexin in ponies: a preliminary investigation.
    Lees P; May SA; Hooke RE; Silley P
    Vet Rec; 1990 Jun; 126(26):635-7. PubMed ID: 2382364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and dialysate concentrations of cephalexin following repeated dosing in CAPD patients.
    Davis GM; Forland SC; Cutler RE
    Am J Kidney Dis; 1985 Sep; 6(3):177-80. PubMed ID: 4036960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronopharmacological study of cephalexin in dogs.
    Prados AP; Ambros L; Montoya L; Rebuelto M
    Chronobiol Int; 2007; 24(1):161-70. PubMed ID: 17364586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin-33 and its receptor ST2 in periapical granulomas and radicular cysts.
    Velickovic M; Pejnovic N; Petrovic R; Mitrovic S; Jeftic I; Kanjevac T; Lukic A
    J Oral Pathol Med; 2016 Jan; 45(1):70-6. PubMed ID: 25677987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.